Convert Pharmaceuticals

About:

Convert Pharmaceuticals is a research and development company.

Website: http://www.convertpharma.com/

Top Investors: Meusinvest (Noshaq), Eurostars, Walloon, Droia Ventures, Spinventure

Description:

Convert Pharmaceuticals is a clinical phase I-IIa drug development company, that is building a proprietary drug pipeline exploiting tumor microenvironment specific factors for therapeutic benefit. Convert’s lead product is a hypoxia activated prodrug (HAP). Hypoxia constitutes a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. Convert Pharmaceuticals combines proprietary insights in the tumor microenvironment with expertise in drug and biomarker development to develop effective and well-tolerated HAPs.